FrontPoint Partners LLC, a US$7.5 billion hedge fund under fire for allegations that a manager benefited from insider information, has received about US$3 billion in redemption requests, according to a letter sent to investors on Friday.
The letter, sent by the co-chief executives, Daniel Waters and Michael Kelly, said roughly US$1.5 billion of those requests came from investors fleeing the firm’s healthcare funds, which are at the center of an insider trading inquiry. The healthcare funds were liquidated on Wednesday, according to the letter, and 97 percent of the funds were returned to investors.
US federal authorities have said that the co-portfolio manager of the healthcare funds received inside information about the results of a clinical drug trial from a French doctor, who was arrested earlier this month. Authorities said the insider tips saved the firm about US$30 million.
The redemption requests come at a time of investor nervousness after US federal agents raided three hedge funds this week, sent subpoenas to several others and arrested one expert accused of trading on insider information.
In their letter, the executives said that some investors indicated that they might rescind their redemption requests, and as a result the firm was hoping to start next year with about US$5 billion in assets under management.
The executives told investors that the firm was stable both financially and operationally, and emphasized that it would survive this rough patch.
Prosecutors say the doctor, Yves Benhamou, gave nonpublic information about a clinical trial for a hepatitis drug to a fund manager, who was later identified as Joseph Skowron, co-manager of FrontPoint’s healthcare funds.
Skowron, who has not been charged and was not named in either the criminal or civil complaint, has been placed on leave from the firm.
A representative for FrontPoint declined to comment. FrontPoint has not been accused of any wrongdoing.
Morgan Stanley, which owns a majority stake in FrontPoint, declined to comment on the redemptions. The Financial Times reported the redemption requests on Friday.
Benhamou was released in lieu of US$3 million bail this week.
He was accused of leaking information from November 2007 to January 2008, while he worked on a steering committee that oversaw the clinical trial of a hepatitis-C drug for Human Genome Sciences, the biopharmaceutical company.
It is unclear what the heavy redemptions will do to a planned spinoff of FrontPoint from Morgan Stanley. A media officer for Morgan Stanley said the company was assessing the impact of the FrontPoint-related events and continued to work toward restructuring its ownership in the hedge fund.
Morgan Stanley acquired the hedge fund stake four years ago for about US$400 million and was on the verge of spinning off a majority stake to Waters and Kelly.
STAYING AHEAD: Fitch said that TSMC remains technologically ahead of others, but Samsung is building a new chip fab, while China is investing in its domestic industry As escalating US-China tensions and COVID-19-related production disruptions force US technology supply chains to transform, Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) US$12 billion chip fabrication plant in Arizona would be key to spurring greater US production of core semiconductor components, Fitch Ratings said. “We view the US-TSMC alliance as a first step in building a more autonomous US technology supply chain, given high barriers to entry, specifically related to the significant capital and design capability required for leading-edge semiconductor manufacturing,” Fitch said in a statement on Tuesday. “By working with TSMC, US chipmakers will not face the financial burden of incremental investment
DIVERSIFICATION: Although COVID-19 would push more companies to produce in emerging markets, DBS said that it was unlikely that firms would totally leave China Geopolitical tensions and supply disruptions are expected to accelerate the migration of manufacturing out of China, as concerns about the risk of production concentrated in one country increase, S&P Global Ratings said. Although its economic expansion might be weaker than previous levels due to the accelerated relocation of manufacturing, China’s economic growth would still be stronger than that of most other economies, the ratings agency said. “While absolute growth rates will moderate, we believe China’s economic performance will continue to be a key sovereign credit support,” S&P Global Ratings credit analyst Tan Kim Eng (陳錦榮) said in a statement on Thursday. “Its growth
Taiwan’s corporate landscape has changed significantly over the past 20 years, with Hon Hai Precision Industry Co (鴻海精密) replacing Formosa Plastics Corp (台塑) as the revenue leader, while Taiwan Semiconductor Manufacturing Co. (TSMC, 台積電) has emerged as the most profitable firm, a survey of Taiwan’s 50 largest companies published on Tuesday last week showed. The Chinese-language CommonWealth Magazine survey ranked Taiwan’s 50 largest companies based on their revenue last year, and compared them with the results of a similar survey it conducted in 2000. Only 33 companies on the original list remained in this year’s rankings, the survey found, following two
The Financial Supervisory Commission (FSC) would set up new guidance by the end of August to boost corporate governance, insurers’ solvency, green financing, financial technology, the trust industry and information security, new FSC Chairman Thomas Huang (黃天牧) said yesterday. “Corporate governance has been improved in terms of compliance and shareholding disclosure with former chairman Wellington Koo (顧立雄) at the helm. It is time to move to the next phase to focus on companies’ roles in sustainable development,” Huang told a news conference in New Taipei City. The commission would also set policies to incentivize companies to increase green financing and adopt the